Post Oesophagectomy Outcomes in a Single Regional Centre in Australia

Launched by LAUNCESTON GENERAL HOSPITAL · Oct 25, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the outcomes of patients who have undergone oesophagectomy, which is surgery to remove part or all of the esophagus (the tube that connects the throat to the stomach), at a regional hospital in Tasmania, Australia. Oesophageal cancer is a serious condition, and while surgery can be a key treatment option, it can also lead to complications. The trial aims to gather information on the short-term and long-term complications and death rates from this surgery in a regional setting, and compare these results to those from larger hospitals that perform more surgeries each year.

To be eligible for this study, patients need to have had an oesophagectomy at Launceston General Hospital between January 2014 and December 2023. There are no specific exclusions, so if you had the surgery during this time, you could be included. Participants in this trial will not have to do anything different; the research will review their medical records from the hospital to understand how well patients have done after surgery. This information is important because it can help improve care for future patients with oesophageal cancer, especially in regional areas where surgeries are still being performed.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients who underwent oeophagectomy at Launceston General Hospital between January 2014 to December 2023
• Exclusion Criteria:
• • none